Sepsis‐induced acute kidney injury: A disease of the microcirculation
- 16 June 2018
- journal article
- research article
- Published by Wiley in Microcirculation
- Vol. 26 (2), e12483
- https://doi.org/10.1111/micc.12483
Abstract
Acute kidney injury (AKI) is a common complication of sepsis and is significantly associated with mortality. Sepsis accounts for more than 50% of the cases of AKI, with a mortality rate of up to 40%. The pathogenesis of septic AKI is complex, but there is emerging evidence that, at least in the first 48 hours, the defects may be functional rather than structural in nature. For example, septic AKI is associated with an absence of histopathological changes, but with microvascular abnormalities and tubular stress. In this context, renal medullary hypoxia due to redistribution of intra‐renal perfusion is emerging as a critical mediator of septic AKI. Clinically, vasopressor drugs remain the cornerstone of therapy for maintenance of blood pressure and organ perfusion. However, in septic AKI there is insensitivity to vasopressors such as norepinephrine, leading to persistent hypotension and organ failure. Vasopressin, angiotensin II and, paradoxically, α2‐adrenergic receptor agonists (clonidine and dexmedetomidine) may be feasible adjunct therapies for catecholamine‐resistant vasodilatory shock. In this review, we outline the recent progress made in understanding how these drugs may influence the renal microcirculation, which represents a crucial step towards developing better approaches for the circulatory management of patients with septic AKI.Keywords
Funding Information
- National Heart Foundation of Australia (NHF, 101853)
- Jack Brockhoff Foundation
This publication has 102 references indexed in Scilit:
- Microcirculatory Alterations in Patients With Severe SepsisCritical Care Medicine, 2013
- Acute kidney injury in non-severe pneumonia is associated with an increased immune response and lower survivalKidney International, 2010
- Effect of dexmedetomidine versus lorazepam on outcome in patients with sepsis: an a priori-designed analysis of the MENDS randomized controlled trialCritical Care, 2010
- Increasing arterial blood pressure with norepinephrine does not improve microcirculatory blood flow: a prospective studyCritical Care, 2009
- The effect of increasing doses of norepinephrine on tissue oxygenation and microvascular flow in patients with septic shock*Critical Care Medicine, 2009
- Long-term Risk of Mortality and Other Adverse Outcomes After Acute Kidney Injury: A Systematic Review and Meta-analysisAmerican Journal of Kidney Diseases, 2009
- Bench-to-bedside review: Vasopressin in the management of septic shockCritical Care, 2009
- Angiotensin II in experimental hyperdynamic sepsisCritical Care, 2009
- Early acute kidney injury and sepsis: a multicentre evaluationCritical Care, 2008
- The histopathology of septic acute kidney injury: a systematic reviewCritical Care, 2008